Product Information
LYRICA 300 MG CAPSULE is a brand product labeled by Pfizer Inc., priced at $9.6852 per EA under NDC 00071101868. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the PREGABALIN market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
300 mg/1
Manufacturer
Pfizer Inc.NDC
00071101868
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
PREGABALINApproval Type
New Drug (NDA)
FDA Application
NDA021446On Market Since
12/30/2004
Price Statistics
The NADAC for LYRICA 300 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 169.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.6852 per EA |
|---|---|
| All-time high | $9.7285 (May 15, 2024) |
| All-time low | $3.5905 (Nov 28, 2013) |
| 52-week high | $9.6931 |
| 52-week low | $9.6761 |
| Median price | $7.8414 |
| Average price | $7.4648 |
| Largest weekly change | +9.4% (Jun 11, 2014) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LYRICA 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LYRICA 300 MG CAPSULE, manufactured by Pfizer Inc., is $9.6852 per EA (NDC 00071101868), effective Jun 24, 2026.
How has the price of LYRICA 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for LYRICA 300 MG CAPSULE has risen 169.7%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LYRICA 300 MG CAPSULE?
Since Nov 28, 2013, the NADAC for LYRICA 300 MG CAPSULE has ranged from a low of $3.5905 (Nov 28, 2013) to a high of $9.7285 (May 15, 2024), with a median of $7.8414 per EA.
Are there cheaper alternatives to LYRICA 300 MG CAPSULE?
Yes. 6 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, PREGABALIN 300 MG CAPSULE, is $0.0658 per EA — about 99% below LYRICA 300 MG CAPSULE.
Who manufactures LYRICA 300 MG CAPSULE?
LYRICA 300 MG CAPSULE (NDC 00071101868) is labeled by Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification